Making good use of bad news on prostate cancer therapy

Making good use of bad news on prostate cancer therapy

I have been arguing for years that treating prostate cancer by attacking testosterone levels made absolutely no sense. Attacking testosterone is not going to cure anything but masculinity.

Men who get prostate cancer are in an age group where their blood testosterone levels are, 75 percent of the time, LOW, not high. By what logic (or statistical mumbo jumbo) have the “experts” come to the conclusion that testosterone is causing prostate cancer?

Why is it that doctors think it is OK to give estrogen to women, ostensibly to prevent aging and cancer, when the kind the doctors have been giving them all these years (an artificial version made from horse urine) has been proven to cause cancer, but it is not OK for a man to take testosterone to prevent aging and cancer when it has not been proven to be carcinogenic? Maybe it’s time for them to hold a conference and iron this out.

In the meantime, a new bit of research may help more men think twice about the negative things their urologists have told them about testosterone.

Less testosterone doesn’t mean more protection

According to a recent article I read, “Men with more advanced prostate cancer often undergo treatment to reduce levels of testosterone, which drives tumor growth. Now, a new study shows that this so-called androgen-deprivation therapy can affect mental performance.”

Let’s clarify a few things here before moving on.

(1) Testosterone does not “drive tumor growth.”
(Please reread paragraph One.)

(2) By “androgen deprivation,” they are talking about giving these male patients estrogen, or estrogen-like hormones. This is illogical and counterproductive. (Please reread paragraph Two.)

Now that we’ve corrected those two mistakes, I, for one, welcome the news about anti-testosterone therapy causing mental changes.

That may sound cruel but if it convinces male patients that they might not be getting an effective treatment for their prostate cancer, then the article is serving a useful purpose. I have advised against testosterone-zapping therapy for prostate cancer for years, but I don’t know of a single patient who followed my advice.

With aggressive prostate cancer, the success rate of this conventional approach is essentially ZERO. And patients with the slow-growing type of prostate cancer don’t need treatment at all-and anything the oncologist/urologist will do is generally counterproductive.

In my opinion, and your urologist will not agree, your first line of defense against prostate cancer is a high blood level of testosterone.

Testosterone is a protective agent and an anti-aging hormone for men. You should try to maintain a testosterone blood level of the average 20-year-old man.


“Estradiol and cognition during androgen deprivation in men with prostate carcinoma.” Cancer 2005; 103(7): 1,381-1,387

“Hormone therapy for prostate cancer affects cognition,” Reuters Health, 3/01/05